Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
CMB Announcements
FDA Confirms Single Pivotal Trial…
CMB
CAMBIUM BIO LIMITED
Market sensitive
FDA Confirms Single Pivotal Trial Pathway for Elate Ocular
Date and time
23 April 2026 at 11:01 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
CMB announcement history
Recent CMB announcements
Updated Securities Trading Policy
Quarterly Activities/Appendix 4C Cash Flow Report
Change in substantial holding - BW
Cleansing Notice
Application for quotation of securities - CMB
Proposed issue of securities - CMB